We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Study of Emerging Pathogens to Better Understand Influenza-Antibody Interactions Could Improve Diagnostics

By LabMedica International staff writers
Posted on 30 Jan 2023
Print article
Image: Scientists have won USD 9.5 million to study emerging pathogens (Photo courtesy of Pexels)
Image: Scientists have won USD 9.5 million to study emerging pathogens (Photo courtesy of Pexels)

Outbreaks of Avian influenza have occurred around the world for over a century. The highly pathogenic H5N1 virus which was first identified in 1996 can lead to severe disease and has a high fatality rate among humans. If the H5N1 virus mutates and becomes easily transmissible from person-to-person while simultaneously maintaining its capability to cause severe disease, there could be serious consequences for public health. For long, scientists have wondered why aquatic birds, particularly ducks, which are carriers of influenza viruses rarely become severely ill themselves. They are yet to find the answer to how their immune systems can be a reservoir for such a highly infectious and pathogenic virus, but still remain mostly unharmed. Also, scientists are yet to find out of the immune system can be engineered to stop transmission of viruses to other animals and humans, thereby preventing future pandemics. Now, a team of investigators will attempt to answer these questions as part of an ambitious, three-year project.

The project involving four faculty members at the University of Illinois Urbana-Champaign (UIUC, Urbana, IL, USA) was one of 13 selected by the Howard Hughes Medical Institute (HHMI, Chevy Chase, MD, USA) as part of its USD 100 million Emerging Pathogens Initiative that will provide USD 9.5 million over three years to the project. The work and the platforms developed by the group over the coming years will help scientists better understand other avian viruses or other host-virus relationships and the steps needed to prevent them from spreading.

The investigators will first attempt to develop ways to purify antibody-producing cells from ducks to better understand their antibody repertoire. They plan to extract immune cells from the blood of ducks, sequence the antibodies and characterize them, to finally assemble a pool of antibodies for further investigations. For instance, the investigators will determine the different strains of influenza an antibody that could be neutralized and how effective those antibodies could be in neutralizing the virus. Based on observations from their sequencing work, the team will translate them into human systems.

The influenza virus enters its host through mucosal routes such as the nasopharynx and lungs and gut. The investigators will adopt various engineering approaches to address the different ways in which the influenza virus invades its hosts. The business part of antibodies is a series of loops that are hypervariable. The immune system selects those loops that bind tightly to a molecule of the pathogen. These loops can be mimicked with circular peptides to create antibody-like molecules. The information derived about the antibodies from ducks and human cells can be used to design the cyclic peptides against avian influenza. Ultimately, their work could have implications beyond influenza. The researchers expect to develop “modular” antibody evolution and engineering platforms that can be easily repurposed for targeting other emerging pathogens. Additionally, the platforms could be adapted for developing biologics to treat other diseases such as cancer.

“We will use the information gathered and combine it with evolution platforms in human cells to study how the duck antibody sequences evolve,” said UIUC chemistry professor Dr. Angad Mehta. “We’ll also engineer and evolve these antibody sequences to make human antibodies. Overall, our efforts could inform biologics development, diagnostics, and vaccine design.”

“We are optimistic that this initiative will help these scientists develop new, untested approaches that can reveal how pathogens work and how the human immune system responds to pathogen infection,” said HHMI Vice President and Chief Scientific Officer Leslie Vosshall. “With this program, we hope to gain some of the knowledge and tools we need to get a scientific head start on future epidemics.”

Related Links:

Gold Supplier
Automated Clinical Chemistry Analyzer
Syphilis Rapid Test
ACON Syphilis Rapid Test
Gold Supplier
D-Dimer Rapid Test
Infection Laboratory Test Panels

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: The new assay enables accurate prognosis and detection data for those prone to esophageal cancer (Photo courtesy of Previse)

First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer

Esophageal cancer is among the most lethal cancers in the world and has a 20% five-year survival rate post-diagnosis. Barrett's esophagus is the sole precursor known and is a significant risk factor for... Read more


view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more


view channel
Image: Artificial intelligence predicts genetics of cancerous brain tumors in under 90 seconds (Photo courtesy of Michigan Medicine)

AI-Based Diagnostic Screening System Predicts Genetics of Cancerous Brain Tumors in 90 Seconds

The diagnosis and treatment of gliomas increasingly rely on molecular classification, as surgical benefits and risks vary depending on a patient's genetic makeup. Complete removal of the tumor can extend... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (Photo courtesy of Roche)

Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's

Presently, obstacles to timely and precise diagnosis of Alzheimer's disease exist globally, resulting in as many as 75% of individuals exhibiting symptoms but lacking a formal diagnosis.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.